000 05257cam a22004697i 4500
999 _c96013
_d96013
005 20260727151748.0
006 m o d
007 cr cnu---unuuu
008 260709s2025 nju o 000 0 eng d
020 _a9781119852285
020 _a9781119852476
_qelectronic book
020 _a1119852471
_qelectronic book
020 _a9781119852445
_qelectronic book
020 _a1119852447
_qelectronic book
020 _a9781119852469
_qelectronic book
020 _a1119852463
_qelectronic book
020 _z9781119852285
_qhardcover
020 _z1119852285
_qhardcover
035 _a(OCoLC)1482532592
035 9 _a(OCLCCM-Owned)1482532592
040 _aYDX
_beng
_erda
_cYDX
_dYDX
_dDG1
_dOCLCO
_dOCLCL
_dSFB
041 _aeng
049 _aMAIN
050 4 _aRS199.5
_b.N68 2025
082 0 0 _223
_a615.6
245 0 0 _aNovel drug delivery systems :
_bfundamentals and applications /
_cedited by Mehrdad Hamidi and Mahsa Sayed Tabatabaei.
264 1 _aHoboken, NJ :
_bJohn WIley & Sons, Inc. ;
_aBeverly, MA :
_bScrivener Publishing LLC,
_c[2025]
300 _a1 online resource
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
505 8 _aCover -- Series Page -- Title Page -- Copyright Page -- Contents -- Preface -- Chapter 1 Introduction to Novel Drug Delivery Systems -- 1.1 Historical Background -- 1.2 Definition, Terminology, and Taxonomy -- 1.3 Novel Drug Delivery Systems: Why, How, and What to Deliver? -- 1.3.1 Why Delivery? -- 1.3.1.1 Liberation -- 1.3.1.2 Absorption -- 1.3.1.3 Distribution -- 1.3.1.4 Metabolism -- 1.3.1.5 Excretion -- 1.3.2 How to Deliver? -- 1.3.2.1 Drug Delivery Barriers -- 1.3.2.2 Overcoming Strategies -- 1.3.2.3 Designing Criteria of NDDSs -- 1.3.3 What to Deliver? -- 1.3.3.1 Small Molecules -- 1.3.3.2 Biopharmaceuticals -- References -- Chapter 2 Novel Drug Delivery Systems: Approach to the Market -- 2.1 Introduction -- 2.2 Novel Drug Delivery Systems Global Market -- 2.2.1 Macroeconomic Indicators Affecting the Market Growth -- 2.2.2 Novel Drug Delivery Systems -- 2.2.3 Key Market Trends
520 8 _aThis book serves as a unique resource on the field of novel drug delivery systems (NDDSs), catering to both academic audiences (researchers, teachers, students) and industry professionals (pharmaceutical policymakers, managers, R&D, regulatory, business development, and marketing) involved in NDDSs. The evolving nature of diseases and the emergence of new health complications have driven a significant shift in drug therapy. Coupled with changes in human lifestyles and economic conditions, these factors have compelled the pharmaceutical industry to develop novel, efficient, and affordable drug products. The rise of promising technologies aimed at enhancing therapeutic performance further underscores the importance of novel drug delivery systems (NDDSs), making this field one of the most dynamic in pharmaceutical sciences today. This book offers a comprehensive exploration of NDDS applications, catering to both academic and industry professionals. It is designed to be both user-friendly and thorough, meeting the needs of diverse readers-from those seeking practical insights to those delving deeply into the field's various sectors. The content has been meticulously compiled, organized, and analyzed by a team of experts to ensure accuracy, relevance, and currency. The book provides up-to-date information suitable for a broad audience, reflecting the wide scope of the NDDS field. The first section covers the foundational principles of NDDS, including their scientific and therapeutic basis, as well as the epidemiological and economic trends driving their development. Subsequent sections explore market-oriented aspects, such as global trends and projections. Chapters 3 to 12 present a taxonomy of NDDS categorized by their routes of administration. The book concludes with a forward-looking report on the potential future directions of NDDS. Written in clear, concise language, the book is accessible to non-native English readers, ensuring broad usability. Original figures, created by experts with scientific and graphic design expertise, enhance the reading experience and aid in understanding complex concepts. Audience A wide variety of professional readers from universities and other research institutions to health industries (industrial pharmaceutical and related), to the relevant high-tech startups to health and pharma policymakers and managers will be among the audiences of this book.
588 _aDescription based on online resource; title from digital title page (viewed on January 08, 2025).
650 0 _aDrug delivery systems.
_0http://id.loc.gov/authorities/subjects/sh88007108
655 4 _aElectronic books.
700 1 _aHamidi, Mehrdad,
_eeditor.
_1https://id.oclc.org/worldcat/entity/E39PCjx7XGb7jtPCFggqbWGVwd
_0http://id.loc.gov/authorities/names/n2011050268
700 1 _aTabatabaei, Mahsa Sayed,
_eeditor.
776 0 8 _iPrint version:
_z1119852285
_z9781119852285
_w(OCoLC)1286954631
856 4 0 _uhttps://onlinelibrary.wiley.com/doi/book/10.1002/9781119852476
_yFull text is available at Wiley Online Library. Click here to view.
942 _2ddc
_cER